The Highland Opportunities and Income Fund announced a monthly dividend of $0.0385 per share, payable on November 30, 2026, to shareholders recorded by November 23, 2026. The closed-end fund invests in a mix of real estate-related securities, loans, bonds, and other instruments aiming for capital growth and income. Investors should note the distribution may include a return of capital and that the fund carries risks including credit, real estate market fluctuations, and liquidity. The fund is managed by NexPoint Asset Management and targets long-term investors rather than short-term trading.
The Highland Opportunities and Income Fund announced a monthly dividend of $0.0385 per share. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 03, 2026 05:41 WIB: out of 142 priced US stocks, 93 rose and 48 fell. Notable movers include BN at USD 41.53 with a 1-day change of +5.73%, UPST at USD 21.75 down -5.52%, and FUTU at USD 103.48 up +5.11%.
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Palantir Technologies reported a strong Q3 with revenue up 96% year-over-year, driven by growth in US commercial sales surpassing government revenue. The company achieved a 62% adjusted operating margin, reinforcing its position in AI technology. Man...
Reconnaissance Energy Africa Ltd. has granted 250,000 stock options to its newly appointed director, Ryan Kubik, at an exercise price of C$0.79 per share, exercisable for five years. This move is designed to align the director's interests with those ...
